Capturing patient-reported and quality of life outcomes with use of shorter regimens for drug-resistant tuberculosis: mixed-methods substudy protocol, TB PRACTECAL-PRO
Guardado en:
Autores principales: | Bern-Thomas Nyang'wa, Beverley Stringer, Nicola James, Karen Lowton |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a9d0cbb4bc45432bbdfd43f466704593 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Population pharmacokinetics and pharmacodynamics of investigational regimens’ drugs in the TB-PRACTECAL clinical trial (the PRACTECAL-PKPD study): a prospective nested study protocol in a randomised controlled trial
por: Bern-Thomas Nyang'wa, et al.
Publicado: (2021) -
Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan
por: Alexandra Wharton-Smith, et al.
Publicado: (2021) -
COULD THE NEW INSIGHTS INTO PZA RESISTANCE PROVIDE ROUTE TO SHORTER MORE EFFECTIVE TB THERAPY?
por: R. M. Anthony
Publicado: (2018) -
The international ENIGMA-II substudy on postoperative cognitive disorders (ISEP)
por: Guy Haller, et al.
Publicado: (2021) -
Case Report: Kanamycin Ototoxicity and MDR-TB Treatment Regimen
por: Mantefardo B, et al.
Publicado: (2021)